This compound is primarily used in targeted protein degradation research. It functions as a proteolysis-targeting chimera (PROTAC), specifically designed to degrade proteins of interest by leveraging the ubiquitin-proteasome system. Its application is significant in studying disease-related proteins, particularly in cancer research, where it helps in understanding protein function and validating potential therapeutic targets. By inducing the degradation of specific proteins, it aids in exploring cellular pathways and developing novel treatment strategies. Its use is also extended to chemical biology and drug discovery, where it serves as a tool to probe protein interactions and functions in various biological contexts.